| Literature DB >> 27925669 |
Pradipta Ghosh1,2, Nicolas Aznar2, Lee Swanson2, I-Chung Lo1, Inmaculada Lopez-Sanchez2, Jason Ear2, Cristina Rohena2, Nicholas Kalogriopoulos2, Linda Joosen2, Ying Dunkel2, Nina Sun2, Peter Nguyen3, Deepali Bhandari3.
Abstract
Canonical signal transduction via heterotrimeric G proteins is spatiotemporally restricted, i.e., triggered exclusively at the plasma membrane, only by agonist activation of G protein-coupled receptors via a finite process that is terminated within a few hundred milliseconds. Recently, a rapidly emerging paradigm has revealed a noncanonical pathway for activation of heterotrimeric G proteins via the nonreceptor guanidine-nucleotide exchange factor, GIV/Girdin. Biochemical, biophysical, and functional studies evaluating this pathway have unraveled its unique properties and distinctive spatiotemporal features. As in the case of any new pathway/paradigm, these studies first required an in-depth optimization of tools/techniques and protocols, governed by rationale and fundamentals unique to the pathway, and more specifically to the large multimodular GIV protein. Here we provide the most up-to-date overview of protocols that have generated most of what we know today about noncanonical G protein activation by GIV and its relevance in health and disease. © 2016 by John Wiley & Sons, Inc.Entities:
Keywords: FRET; GIV/Girdin; immunoblotting; immunofluorescence; immunoprecipitation; in cellulo GST-pull down; trimeric G proteins
Mesh:
Substances:
Year: 2016 PMID: 27925669 PMCID: PMC5154557 DOI: 10.1002/cpch.13
Source DB: PubMed Journal: Curr Protoc Chem Biol ISSN: 2160-4762